PepsiCo is steadfast on its long-term growth target despite falling short in 2024, with an emphasis on better-for-you in ...
CEO Ramon Laguarta said the Doritos maker hasn’t seen a “direct impact” from GLP-1 medications despite higher consumer interest in health and wellness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback